Anti-cancer effect of thiacremonone through down regulation of peroxiredoxin 6

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Jo, Miran ^a   Yun, Hyung Mun ^a   Park, Kyung Ran ^a   Park, Mi Hee ^a   Lee, Dong Hun ^a   Cho, Seung Hee ^a   Yoo, Hwan Soo ^a   Lee, Yong Moon ^a   Jeong, Heon Sang ^a   Kim, Youngsoo ^a   Jung, Jae Kyung ^a   Hwang, Bang Yeon ^a   Lee, Mi Kyeong ^a   Kim, Nam Doo ^b   Han, Sang Bae ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Daegu Gyeongbuk Medical Innovation Foundation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 8; CASPASE 9; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INHIBITOR OF APOPTOSIS PROTEIN; PEROXIREDOXIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN CIAP; PROTEIN P21; PROTEIN P53; THIACREMONONE; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; PLANT EXTRACT; PROTEIN BINDING; THIOPHENE DERIVATIVE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL STRAIN A549; CELL STRAIN NCI H460; CELL VIABILITY ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN INTERACTION; WESTERN BLOTTING; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DISEASE MODEL; DRUG EFFECTS; GARLIC; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; NEOPLASMS; PATHOLOGY; REPORTER GENE; TUMOR CELL LINE; TUMOR VOLUME;

ALLOGRAFTS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GARLIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUTATION; NEOPLASMS; PEROXIREDOXIN VI; PLANT EXTRACTS; PROTEIN BINDING; THIOPHENES; TUMOR BURDEN;

EID: 84897548590     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091508     Document Type: Article

References (36)

1. Kim SY, Jo HY, Kim MH, Cha YY, Choi SW, et al. (2008) H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J Biol Chem 283: 33563-33568.
2. Fatma N, Kubo E, Sen M, Agarwal N, Thoreson WB, et al. (2008) Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis. Brain Res 1233: 63-78.
3. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K (2001) Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52: 35-41. (Pubitemid 33769667)
4. Ho JN, Lee SB, Lee SS, Yoon SH, Kang GY, et al. (2010) Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol Cancer Ther 9: 825-832.
5. Flohe L, Budde H, Hofmann B (2003) Peroxiredoxins in antioxidant defense and redox regulation. Biofactors 19: 3-10. (Pubitemid 38073139)
6. Kang SW, Baines IC, Rhee SG (1998) Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. J Biol Chem 273: 6303-6311. (Pubitemid 28144720)
7. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, et al. (2002) 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxida-tion-mediated membrane damage. Proc Natl Acad Sci U S A 99: 11599-11604. (Pubitemid 34994445)
8. Dhakshinamoorthy S, Long DJ 2nd, Jaiswal AK (2000) Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36: 201-216.
9. Chowdhury I, Mo Y, Gao L, Kazi A, Fisher AB, et al. (2009) Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic Biol Med 46: 146-153.
10. Baker AF, Landowski T, Dorr R, Tate WR, Gard JM, et al. (2007) The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response. Clin Cancer Res 13: 3388-3394. (Pubitemid 46944927)
11. Neumann CA, Fang Q (2007) Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7: 375-380. (Pubitemid 47289263)
12. Pak JH, Choi WH, Lee HM, Joo WD, Kim JH, et al. (2011) Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest 29: 21-28.
13. Walsh B, Pearl A, Suchy S, Tartaglio J, Visco K, et al. (2009) Overexpression of Prdx6 and resistance to peroxide-induced death in Hepa1-6 cells: Prdx suppression increases apoptosis. Redox Rep 14: 275-284.
14. Lee SB, Ho JN, Yoon SH, Kang GY, Hwang SG, et al. (2009) Peroxiredoxin 6 promotes lung cancer cell invasion by inducing urokinase-type plasminogen activator via p38 kinase, phosphoinositide 3-kinase, and Akt. Mol Cells 28: 583-588.
15. Schremmer B, Manevich Y, Feinstein SI, Fisher AB (2007) Peroxiredoxins in the lung with emphasis on peroxiredoxin VI. Subcell Biochem 44: 317-344.
16. Lee Y, Kim H, Lee J, Kim K (2011) Anticancer activity of S-allylmercapto-Lcysteine on implanted tumor of human gastric cancer cell. Biol Pharm Bull 34: 677-681.
17. Kwon OC, Woo KS, Kim TM, Kim DJ, Hong JT, et al. (2006) Physicochemical characteristics of garlic (Allium sativum L.) on the high temperature and pressure treatment. Korean J Food Sci Technol 2006;38:331-336
18. O'Donovan TR, O'Sullivan GC, McKenna SL (2011) Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509-524.
19. Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, et al. (2012) Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 72: 82-89.
20. Druesne-Pecollo N, Latino-Martel P (2011) Modulation of histone acetylation by garlic sulfur compounds. Anticancer Agents Med Chem 11: 254-259.
21. Lai KC, Kuo CL, Ho HC, Yang JS, Ma CY, et al. (2012) Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo. Phytomedicine 19: 625-630.
22. Bat-Chen W, Golan T, Peri I, Ludmer Z, Schwartz B (2010) Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr Cancer 62: 947-957.
23. Iciek M, Kwiecien I, Chwatko G, Sokolowska-Jezewicz M, Kowalczyk-Pachel D, et al. (2012) The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells. Cell Biochem Funct 30: 198-204.
24. Kim SH, Bommareddy A, Singh SV (2011) Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 4: 897-906.
25. Nagaraj NS, Anilakumar KR, Singh OV (2010) Diallyl disulfide causes caspase-dependent apoptosis in human cancer cells through a Bax-triggered mitochondrial pathway. J Nutr Biochem 21: 405-412.
26. Xiao D, Zeng Y, Hahm ER, Kim YA, Ramalingam S, et al. (2009) Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells. Environ Mol Mutagen 50: 201-212.
27. Ban JO, Yuk DY, Woo KS, Kim TM, Lee US, et al. (2007) Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfurcompound isolated from garlic in human colon cancer cells. J Pharmacol Sci 104: 374-383.
28. Ng KT, Guo DY, Cheng Q, Geng W, Ling CC, et al. (2012) A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One 7: e31655.
29. Pei Y, Wu B, Cao Q, Wu L, Yang G (2011) Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells. Toxicol Appl Pharmacol 257: 420-428.
30. Chatterjee S, Feinstein SI, Dodia C, Sorokina E, Lien YC, et al. (2011) Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J Biol Chem 286: 11696-11706.
31. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, et al. (2007) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 9: R76.
32. Fisher AB (2011) Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal 15: 831-844.
33. Zhang XZ, Xiao ZF, Li C, Xiao ZQ, Yang F, et al. (2009) Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 100: 2396-2401.
34. Conti A, Rodriguez GC, Chiechi A, Blazquez RM, Barbado V, et al. (2011) Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 178: 88-97.
35. Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, et al. (2008) Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells. Mol Pharmacol 73: 119-127. (Pubitemid 350294203)
36. Cao M, Li Q, Zhang Z, Jia H and Gu S (2009) [The quantitative analysis of the oxidants/antioxidants in the tissues of lung cancer patients.]. Zhongguo Fei Ai Za Zhi 12: 322-326.